Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT04939116
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Angion Biomedica Corp
- Registry
-
NCT04939116
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Georgia
- Registry status
- Unknown status
Technical summary
Registry record NCT04939116. Randomized; triple masking; primary purpose treatment. Start 2021-12-24 (actual); primary completion 2023-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
- Condition
- Glomerular Disease
- Condition
- Proteinuria
- Intervention (Drug)
- ANG-3070
- Intervention (Drug)
- Placebo
- Lead sponsor
- Angion Biomedica Corp
Record details
- Record id
cardio:ct-nct04939116- Content hash
1c36c4b283595ad3ddd84e2dfc3c5815a34856e2ca004c4c6eccb34de29790fd